Finolex Industries Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹1,314Cr
- +12.1% YoY
- +46.3% QoQ
- Net profit
- ₹261Cr
- +58.2% YoY
- +125% QoQ
- Margin
- 25%
- +10 pp YoY
- +11 pp QoQ
Top 10 Industrial Products companies on management guidance
See the sector's top 10 — free with your mobile number.
The short version
Finolex Industries targets a volume growth of higher single digit to lower double digit for the upcoming full year (FY27). Finolex targets a volume growth of higher single digit to low double digit for FY27.
From Finolex Industries Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Finolex Industries targets a volume growth of higher single digit to lower double digit for the upcoming full year (FY27).
- Current production capacity of 520,000 tonnes is sufficient to support volume growth in FY26 and FY27 without immediate expansion.
- The company plans to incur annual capex of INR 100-200 crores primarily for maintenance and capacity debottlenecking, facilitating gradual capacity increase.
- Shift from agri-focused business (63% in FY26) towards a more balanced agri and non-agri portfolio, aiming for an ideal 50:50 split in 4-5 years, which could enhance revenue and margin profile.
2 more points from Finolex Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Finolex Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Finolex Industries plans a consistent annual capex of around INR 100 crore to INR 200 crore focused on capacity augmentation and maintenance.
- Current efforts include debottlenecking processes, such as replacing lower capacity extruders with higher capacity ones, to increase production capability.
- The existing total capacity is 520,000 tons, which is sufficient for near-term volume growth without immediate need for further expansion.
- The company is open to reconsidering geographic expansion and diversification of manufacturing locations in the future if suitable opportunities arise, especially for non-agri products.
2 more points from Finolex Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Industrial Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Finolex Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Finolex Industries Ltd said on order book & pipeline — free account, 30 seconds.
Finolex Industries Ltd — Quarterly revenue & net profit
Finolex Industries Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 1,314 | 1,172 | +12.1% | 898 | +46.3% |
| Operating profit (EBITDA) | 332 | 171 | +94.2% | 123 | +169.9% |
| Operating margin | 25% | 15% | +10 pp | 14% | +11 pp |
| Profit before tax | 351 | 223 | +57.4% | 157 | +123.6% |
| Net profit (PAT) | 261 | 165 | +58.2% | 116 | +125% |
| EPS (₹) | 4.21 | 2.65 | +58.9% | 1.87 | +125.1% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.1K Cr, net profit ₹115 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Finolex Industries's management said in earlier quarters
Others in Industrial Products this season
- Aeron Composites (Q4 FY26)
For H2 FY26, revenue from operations was ₹103 Cr; for H1 FY26, ₹118.8 Cr, totaling ₹221.8 Cr for FY26. Key investor presentation takeaways from Aeron Composites
- Shera Energy (Q4 FY26)
Total Income (Revenue) for FY26 is ₹1,646.73 Cr, up from ₹1,279.05 Cr in FY25, indicating a year-on-year growth of around 29%. Key investor presentation takeawa
- Sarthak Metals (Q4 FY26)
Q4 FY26 Revenue from Operations: ₹61.99 crore (Page 6) . Key investor presentation takeaways from Sarthak Metals Ltd's Q4 FY26 investor presentation — and how i
- De Neers Tools (Q4 FY26)
Quarterly Revenue (H2FY26):** ₹1,056.8 Mn, up 40.5% YoY (Page 14) . Key investor presentation takeaways from De Neers Tools's Q4 FY26 investor presentation — an
Potential multibaggers · Q2 FY27
Potential multibaggers in Industrial Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Finolex Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Finolex Industries Ltd Q4 FY26 results?
Finolex Industries targets a volume growth of higher single digit to lower double digit for the upcoming full year (FY27). Finolex targets a volume growth of higher single digit to low double digit for FY27.
What is Finolex Industries Ltd share price analysis?
Finolex Industries Ltd currently shows a neutral. The stock trades at a P/E of 17.3 with a market cap of ₹10,371 Cr. Investors should review the full earnings analysis for detailed insights.
Is Finolex Industries Ltd planning capital expenditure?
Finolex Industries plans a consistent annual capex of around INR 100 crore to INR 200 crore focused on capacity augmentation and maintenance.
Keep Finolex Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
